The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
https://uk.finance.yahoo.com/news/germany-lifts-travel-ban-for-31-countries-including-uk-112613086.html
This is only just getting warmed up.
think you mean 213.
See you there.
Can't see this holding much longer. Will get back in at around 113
Great find on that RNS...a very important RNS - and will bode very positively for short term opening capability
Hi, Convb, just in Menz.
TheGreatMaze...great story/link thank you.
Are you invested in Westminster?
https://www.investegate.co.uk/westminster-group--wsg-/rns/fever-screening-trials-at-stockholm-airport/202006030700047369O/
Westminster Group
Fever Screening Trials at Stockholm Airport
RNS Number : 7369O
Westminster Group PLC
03 June 2020
Westminster Group Plc
('Westminster', the 'Group' or the 'Company')
Fever Screening Trials at Stockholm Arlanda Airport
Westminster Group Plc (AIM: WSG), a leading supplier of managed services and technology-based security solutions worldwide, is pleased to announce that it has conducted a successful trial of its fever screening solutions in association with Menzies Aviation and their client, Air France, at Stockholm Arlanda Airport.
Using the Westminster fever screening solution, Menzies Aviation will continue to conduct operational trials with Air France and other clients' flights' over the coming weeks in order to fine tune an effective delivery to this added layer of safety and security. Feedback from the first live trial was extremely positive with all passengers screened as they presented their boarding passes at the departure gate. The trial at Stockholm Arlanda Airport is Westminster's first trial at a Scandinavian airport as it looks to widen its client database and airport presence.
Commenting on the trial Westminster's General Manager, Hamish Russell, said:
"Working with Menzies Aviation on the trial has been excellent. We have worked hard in order to supply them with the correct solution for their fever screening requirements that is fit for purpose and has the least impact on an already complex procedure, and within the required time frame. I need to thank all those involved at Menzies Aviation both in the UK and their team in Sweden for their efforts.
"Westminster's fever screening solutions have been supplied to numerous industry sectors to detect, mitigate and defeat the spread of COVID-19. Westminster continues to add to its fever screening offering ensuring products are adaptable, cost effective and can be implemented and upgraded into existing processes or technology."